Comparison of an oral factor Xa inhibitor with low molecular weight heparin in cancer patients with venous thromboembolism : results of a randomized trial (SELECT-D)

Article English OPEN
Young, Annie M.; Marshall, Andrea; Thirlwall, Jenny; Chapman, Oliver; Lokare, Anand; Hill, Catherine; Hale, Danielle; Dunn, Janet A.; Lyman, Gary H.; Hutchinson, Charles; MacCallum, Peter; Kakkar, Ajay; Hobbs, F. D. Richard; Petrou, Stavros; Dale, Jeremy; Poole, Christopher J.; Maraveyas, Anthony; Levine, Mark; HASH(0x5576ca77e6f8);
(2018)

Purpose: \ud \ud Venous thromboembolism (VTE) is common in cancer patients. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients. The purpose of this study was to assess if an oral Factor Xa inhibitor, rivaroxaban, woul... View more
Share - Bookmark